No abstract available
MeSH terms
-
Administration, Oral
-
Age Factors
-
Anticoagulants / administration & dosage
-
Anticoagulants / therapeutic use*
-
Atrial Fibrillation / complications
-
Atrial Fibrillation / drug therapy*
-
Atrial Fibrillation / mortality
-
Diabetes Complications / etiology
-
Disease-Free Survival
-
Drug Prescriptions
-
Drug Therapy, Combination
-
Fibrinolytic Agents / administration & dosage
-
Fibrinolytic Agents / therapeutic use*
-
Health Status Indicators*
-
Heart Failure / complications
-
Humans
-
Incidence
-
Platelet Aggregation Inhibitors / administration & dosage
-
Platelet Aggregation Inhibitors / therapeutic use*
-
Practice Guidelines as Topic
-
Risk Assessment
-
Risk Factors
-
Stroke / etiology
-
Stroke / mortality
-
Stroke / prevention & control*
-
Time Factors
-
Treatment Outcome
Substances
-
Anticoagulants
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors